Back to AUPH

Aurinia Pharmaceuticals Inc. 6-K

Accession 0001628280-20-005759

Filing information

CIK
0001600620
Report date
2020-05-31
Filing date
2020-04-28
Form
6-K
Primary document
auph-2020agm6xk.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.